INIS
coumarins
100%
drugs
57%
thrombin
50%
solubility
50%
thrombosis
48%
inhibition
39%
design
37%
capillaries
33%
ligands
31%
molecular weight
27%
synthesis
25%
structure-activity relationships
25%
electrophoresis
25%
libraries
25%
water
25%
evaluation
25%
microanalysis
25%
tools
25%
assessments
25%
lectures
25%
affinity
25%
plasma
25%
blood
25%
molecules
25%
enzymes
24%
diseases
23%
values
22%
risks
20%
serine
20%
screening
18%
increasing
18%
kinetics
16%
hybrids
16%
substrates
16%
comparative evaluations
14%
kinins
12%
kallikrein
12%
protection
12%
devices
12%
anticoagulants
11%
in vivo
11%
death
11%
coumarin
11%
industrialized countries
11%
dimers
8%
receptors
8%
x radiation
8%
injection
8%
sensitivity
8%
modeling
8%
Keyphrases
Partial Filling Capillary Electrophoresis
25%
Fragment-based Drug Discovery
25%
Hereditary Angioedema
25%
Argatroban
25%
Evaluation Activities
25%
Electrophoretically Mediated Microanalysis
25%
Positive Allosteric Modulator
25%
Novel Developments
25%
GluA2
15%
In Vivo Function
12%
Emerging Research Topics
12%
Phage Display Library
12%
UV Detection
12%
Enzymatic Reaction
12%
Kinetic Constraints
12%
Cell-based Assay
12%
Chromogenic Substrate
12%
Injection Sequence
12%
Inhibitory Constant
12%
Separation Condition
12%
Kallikrein-kinin System
12%
Hematophagous Arthropods
12%
Library Technology
12%
Neuroinflammatory Disorders
12%
Thrombotic
8%
Fragment Growing
6%
Structure-guided
6%
Affinity CE
6%
Low-molecular-weight Ligand
6%
Analytical Screening
6%
Partial Filling
6%
Discriminatory Power
6%
Nafamostat
6%
CE Method
6%
Benzamidine
6%
Fragment Merging
6%
Small Molecular Weight Inhibitors
6%
Blood-contacting Medical Devices
6%
Microfluidic Model
6%
Device-related Thrombus
6%
Contact Factor
6%
Plasma Factors
6%
Thromboelastometry
6%
FXIa
6%
Enzyme Assay
6%
Plasma Assays
6%
Plasma Kallikrein
6%
Contact Phase
5%
Calcium Flux
5%
AMPA Receptor (AMPAR)
5%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombosis
50%
Coumarin Derivative
50%
Anticoagulant Agent
43%
Carboxamide
35%
Bleeding
29%
Blood Clotting Factor 12
25%
Argatroban
25%
Positive Allosteric Modulator
25%
Disease
14%
Blood Clotting Factor
14%
Serine Proteinase
14%
Coumarin
14%
Pharmacokinetics
14%
Chromogenic Substrate
12%
Buffer
12%
Plasma Kallikrein
12%
Structure Activity Relationship
8%
Enzyme Precursor
8%
Mouse
6%
Benzamidine
6%
4 Aminobenzamidine
6%
Nafamstat
6%
Angioneurotic Edema
6%
Imidazole
6%
Hemostatic Agent
5%
AMPA Receptor
5%
